The prevalence, awareness and treatment of high low density lipoprotein-cholesterol in Korean adults without coronary heart diseases - The Third Korea National Health and Nutrition Examination Survey, 2005

Korean Circulation Journal

Volumn 42, Issue 2, 2012, Pages 86-94

  Choi, Sun Ja ^a   Park, Sung Hee ^a   Lee, Kwang Soo ^a   Park, Hyun Young ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Coronary heart disease; Dyslipidemia; Low density lipoprotein cholesterol

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; AWARENESS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HEALTH SURVEY; HUMAN; KOREA; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT;

EID: 84863233080     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2012.42.2.86     Document Type: Article

References (32)

1. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. (Pubitemid 28213628)
2. Castelli WP. Epdemilology of coronary heart disease: the Framingstudy. Am J Med 1984;76:4-12. (Pubitemid 14151605)
3. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: finding form long-term follow-up of Chicago cohorts. Cardiology 1993;82:191-222. (Pubitemid 23182028)
4. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000;284:311-8. (Pubitemid 30469857)
5. In-Depth Analysis of the Third Korea National Health and Nutrition Examination Survey (KNHANES III). Seoul: Korea Centers for Disease Control and Prevention;2007.
6. Lim S, Jang HC, Park HC, et al. Changes in metabolic syndrome of Korean children and adolescents in the period 1998 to 2001. J Endocrinol Invest 2008;31:327-33. (Pubitemid 351796619)
7. The Lipid Research Clinics Coronary Primary Prevention Trial. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64.
8. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousidian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986;256:2835-8. (Pubitemid 17178361)
9. Frick MH, Elo O, Haapak M, et al. Helsinki Heart Study: primary prevention trial with gemfibrozil in middled-aged men with dyslipidemia: safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl J Med 1987;317:1237-45. (Pubitemid 17147964)
10. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-74.
11. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110:227-39. (Pubitemid 38924592)
12. Committee of treatment guideline for hypercholesterolemia. Treatment guideline for hypercholesterolemia. 2nd ed. Seoul: Korea Society of lipidology and atherosclerosis;2008.
13. Ko M, Kim MT, Nam JJ. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Int J Cardiol 2006;110:184-90. (Pubitemid 43767100)
14. Siegel D. The gap between knowledge and practice in the treatment and prevention of cardiovascular disease. Prev Cardiol 2000;3:167-71.
15. Smaha LA. The American Heart Association get with the guidelines program. Am Heart J 2004;148(5 Suppl):S46-8.
16. Sung J, Kim SH, Kim YD, et al. Ten centers study on the present state of treatment for hypercholesterolemia in patients with coronary artery disease. Korean J Med 2005;69:371-8.
17. Kim SH, Park JS, Zo JH, Kim MA, Kim HS. Treatment gap in the management of hypercholesterolemia in Korea: return on expenditure achieved for lipid therapy (REALITY). Korean Circ J 2006;36:593-9.
18. June JE. Cholesterol lowering therapy in coronary artery disease: with particular reference to statins. Korean Circ J 2001;31:849-56.
19. Kim MK, Kim HL, Min HS, et al. Changes of the lipoprotein profiles with time after discontinuation of stain therapy. Korean Circ J 2008;38:36-42.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Annual report on the cause of death statistics. Seoul: Korean National Statistical Office;2006.
22. Hyre AD, Muntner P, Menke A, Raggi P, He J. Trends in ATP-III defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol 2007;17:548-55. (Pubitemid 46950925)
23. Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J 2008;156:112-9.
24. Lee YW, Min WK, Lee W, et al. Risk analysis of coronary heart diseases in Korean adults by using the National Cholesterol Education Program Adult Treatment Panel III. J Clin Lab Anal 2007;21:178-82. (Pubitemid 46808911)
25. Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Clin Ther 2007;29:1671-81. (Pubitemid 47500127)
26. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2-14.
27. Schaefer FJ, Levy RI, Anderson DW, Danner RN, Brewer HB Jr, Blackwelder WC. Plasma-triglycerides in regulation of HDL-cholesterol levels. Lancet 1978;2:391-3.
28. Casteli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986;112:432-7.
29. Hong HS, Park JS, Ryu HK, Kim WY. The association of plasma HDL-cholesterol level with cardiovascular disease related factors in Korean type 2 diabetes patients. Korean Diabetes J 2008;32:215-23.
30. Park SH, Choi SJ, Lee KS, Park HY. Waist circumference and waist-to-height ratio as predictors of cardiovascular disease risk in Korean adults. Circ J 2009,73:1643-50.
31. Bersot T, Pépin GM, Mahley RW. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J 2003;146:1052-9.
32. National Health Insurance Corporation. Insurance standard of dyslipidemia. Avail from: http://www.nhic.or.kr/.